data_5x35_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x35 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.784 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.44 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.4 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.784 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.428 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.795 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.8 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.518 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.518 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.8 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.402 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HD22 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD22 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.489 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 . . . . . 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 8.3 t-160 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.439 -0.982 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.603 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.594 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 tp-100 . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.464 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.752 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.463 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.752 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -93.55 146.29 23.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.784 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.44 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.784 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.29 144.04 28.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.499 ' H ' ' H61' ' A' ' 101' ' ' MAN . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.428 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.499 ' H61' ' H ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 23.1 p . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.725 0.298 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 -88.81 144.72 26.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.795 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 1' ' ' THR . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.612 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.2 140.94 31.38 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.8 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.518 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.518 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.8 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -113.54 140.29 48.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.773 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HA ' ' H62' ' A' ' 101' ' ' MAN . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.402 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HD22 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD22 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.439 ' H62' ' HA ' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -103.31 138.81 39.57 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.807 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.807 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 -81.49 144.06 31.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.489 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 -108.78 140.38 42.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -85.95 137.3 32.83 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 8.3 t-160 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -88.41 145.0 26.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.829 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.829 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -88.61 142.14 27.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.464 ' HB2' ' HO4' ' A' ' 101' ' ' MAN . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.464 ' HO4' ' HB2' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.401 HG22 ' HO6' ' A' ' 101' ' ' MAN . 41.1 p . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 -99.63 133.41 44.0 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.605 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.767 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.603 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.767 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.401 ' HO6' HG22 ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.239 0.536 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.65 143.48 31.88 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HA ' ' H1 ' ' A' ' 101' ' ' MAN . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.475 ' H1 ' ' HA ' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.594 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 -94.92 139.56 31.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 tp-100 -82.58 137.46 34.54 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.61 138.4 31.53 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 128.85 38.29 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.713 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.464 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 -81.51 140.78 34.35 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.813 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.75 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.75 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.584 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 -87.05 125.51 34.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -80.68 140.63 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 118.067 0.394 . . . . 0.0 110.129 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.752 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.463 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.686 ' OG ' ' H4 ' ' A' ' 101' ' ' MAN . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.752 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.686 ' H4 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.43 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.809 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.813 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 17' ' ' THR . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.404 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' HD12 ' A' ' 28' ' ' LEU . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 . . . . . 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 32' ' ' TYR . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 28' ' ' LEU . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.836 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.836 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.439 -0.982 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.518 ' CE2' HD12 ' A' ' 28' ' ' LEU . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.591 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 53.8 tp60 . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.782 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.473 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.473 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.411 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.411 HD21 HE21 ' A' ' 34' ' ' GLN . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.409 HE21 HD21 ' A' ' 36' ' ' LEU . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD21 HE21 ' A' ' 34' ' ' GLN . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -93.55 146.29 23.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.29 144.04 28.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.574 ' H ' ' H61' ' A' ' 101' ' ' MAN . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.43 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.574 ' H61' ' H ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 23.1 p . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.725 0.298 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 -88.81 144.72 26.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.809 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' THR . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.586 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.2 140.94 31.38 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.813 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 17' ' ' THR . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -113.54 140.29 48.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' H62' ' A' ' 101' ' ' MAN . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.491 ' H62' ' HA ' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -103.31 138.81 39.57 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 -81.49 144.06 31.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' HD12 ' A' ' 28' ' ' LEU . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 -108.78 140.38 42.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -85.95 137.3 32.83 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 32' ' ' TYR . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 28' ' ' LEU . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -88.41 145.0 26.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.836 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.836 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -88.61 142.14 27.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 -99.63 133.41 44.0 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.518 ' CE2' HD12 ' A' ' 28' ' ' LEU . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.239 0.536 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.65 143.48 31.88 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.426 HG21 ' O5 ' ' A' ' 101' ' ' MAN . 23.6 p . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.591 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 -94.92 139.56 31.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.426 ' O5 ' HG21 ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 53.8 tp60 -82.58 137.46 34.54 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.782 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -92.61 138.4 31.53 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 128.85 38.29 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.473 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.473 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 -81.51 140.78 34.35 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.813 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.411 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.411 HD21 HE21 ' A' ' 34' ' ' GLN . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.538 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 -87.05 125.51 34.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -80.68 140.63 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 118.067 0.394 . . . . 0.0 110.129 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.677 ' OG ' ' H4 ' ' A' ' 101' ' ' MAN . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.409 HE21 HD21 ' A' ' 36' ' ' LEU . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD21 HE21 ' A' ' 34' ' ' GLN . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.677 ' H4 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.43 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.809 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.813 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 17' ' ' THR . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.404 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' HD12 ' A' ' 28' ' ' LEU . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 . . . . . 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 32' ' ' TYR . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 28' ' ' LEU . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.836 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.836 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 . . . . . 0 N--CA 1.439 -0.982 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.518 ' CE2' HD12 ' A' ' 28' ' ' LEU . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.591 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 tp-100 . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.782 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.6 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.473 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 32' ' ' TYR . 41.5 m-80 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.473 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.411 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.411 HD21 HE21 ' A' ' 34' ' ' GLN . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.444 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.409 HE21 HD21 ' A' ' 36' ' ' LEU . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD21 HE21 ' A' ' 34' ' ' GLN . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -93.55 146.29 23.9 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 120.866 0.365 . . . . 0.0 110.105 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -87.22 172.7 9.71 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.23 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 9.1 t-160 -66.61 129.56 40.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 76.26 15.7 2.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.29 1.036 . . . . 0.0 112.64 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.42 159.27 17.84 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.6 tt0 -78.02 113.78 16.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.5 p -76.94 -67.16 0.74 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.71 83.95 0.08 OUTLIER Glycine 0 CA--C 1.478 -2.27 0 C-N-CA 118.825 -1.655 . . . . 0.0 113.107 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 177.61 29.32 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.36 121.66 13.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 117.487 0.643 . . . . 0.0 110.125 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.46 -10.15 45.94 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.905 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -101.61 133.2 46.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.3 p -126.54 18.81 7.44 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.4 -144.19 15.54 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.629 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 43.8 Cg_endo -69.8 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.859 2.373 . . . . 0.0 112.341 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -84.29 -27.19 28.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.18 123.14 38.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 79.3 m -76.41 155.93 33.59 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.104 0.478 . . . . 0.0 111.869 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.25 169.1 11.05 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.512 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 p -64.78 117.82 8.07 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.119 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.08 12.12 43.72 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.985 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 63.1 p -134.1 141.95 47.33 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.7 p -114.97 144.36 43.72 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.6 t -78.08 95.83 4.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -91.72 124.35 35.79 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.777 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.76 96.96 4.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.06 -37.35 54.77 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.696 0.76 . . . . 0.0 109.241 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -144.82 164.21 28.88 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.68 -31.56 92.32 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.04 1.827 . . . . 0.0 112.54 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -101.95 -26.95 13.23 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.685 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -103.99 114.45 28.7 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.344 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.5 m -125.0 137.35 54.24 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.5 tt0 -128.85 139.32 52.21 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 118.086 0.403 . . . . 0.0 111.433 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.794 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.4 m -75.34 108.97 8.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.4 mt . . . . . 0 C--N 1.292 -1.897 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.671 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.29 144.04 28.33 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -83.54 166.24 18.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -60.46 128.62 37.58 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 77.99 11.48 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.967 1.307 . . . . 0.0 112.895 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.62 159.1 21.61 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.1 tt0 -83.02 107.68 15.79 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.0 p -73.71 -61.53 1.81 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.043 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.13 91.01 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.191 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.156 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.69 179.83 30.47 Favored Glycine 0 C--N 1.293 -1.857 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 172.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.8 mt -62.23 115.82 2.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 117.778 0.789 . . . . 0.0 110.231 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.14 -15.93 32.95 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.364 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -92.22 120.44 32.79 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -115.59 21.89 13.6 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.09 -148.01 20.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.979 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 104.05 1.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.283 1.989 . . . . 0.0 111.264 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.5 p -87.63 -18.7 29.02 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.562 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.86 117.13 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-O 120.909 0.385 . . . . 0.0 110.012 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.5 m -77.31 157.59 30.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.946 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.4 166.91 11.48 Favored 'General case' 0 C--O 1.253 1.241 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.453 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.574 ' H ' ' H61' ' A' ' 101' ' ' MAN . 3.5 p -60.86 118.67 6.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 124.214 1.006 . . . . 0.0 111.262 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.82 -9.87 48.03 Favored Glycine 0 N--CA 1.431 -1.654 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.054 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.1 p -117.26 137.42 52.4 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 117.07 0.435 . . . . 0.0 110.724 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.6 p -105.69 143.93 33.15 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -77.61 101.88 6.76 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 74.7 mt-30 -99.0 120.06 38.82 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.196 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.72 100.43 2.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 39.8 mt -83.3 -41.35 18.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -132.29 163.68 48.69 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.88 -33.83 98.79 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.521 1.481 . . . . 0.0 111.754 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.43 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.4 m-85 -100.75 -25.55 14.09 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.161 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 59.9 t80 -103.24 113.98 27.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.956 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -118.72 137.75 53.13 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.6 tt0 -128.57 139.97 52.02 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 117.669 0.213 . . . . 0.0 110.86 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.6 m -77.59 105.58 8.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.972 0.415 . . . . 0.0 110.646 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.6 mt . . . . . 0 C--N 1.292 -1.907 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.574 ' H61' ' H ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 23.1 p . . . . . 0 CA--C 1.507 -0.675 0 CA-C-O 120.725 0.298 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.538 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.8 tp-100 -88.81 144.72 26.04 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -85.9 162.23 18.69 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.147 0.499 . . . . 0.0 110.935 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -59.31 131.67 51.7 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.969 0.908 . . . . 0.0 108.695 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 77.04 12.02 2.31 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.293 1.037 . . . . 0.0 113.207 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.75 157.98 16.48 Favored Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' SER . 20.8 tt0 -76.17 107.42 8.39 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.809 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -70.48 -64.92 0.8 Allowed 'General case' 0 C--O 1.211 -0.971 0 O-C-N 123.802 0.689 . . . . 0.0 112.401 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.35 69.52 0.18 Allowed Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.586 -1.769 . . . . 0.0 113.021 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.93 -179.75 52.77 Favored Glycine 0 C--N 1.302 -1.319 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.67 117.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 117.489 0.645 . . . . 0.0 110.539 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.62 37.53 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.972 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -109.3 128.55 55.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.6 p -131.7 6.53 4.37 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.11 -131.31 0.48 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.399 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.0 Cg_endo -68.44 87.43 0.41 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.368 2.045 . . . . 0.0 111.795 177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.0 p -86.75 -29.23 22.52 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.599 -175.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' THR . 88.9 t -81.1 129.08 38.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.81 165.79 20.56 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.247 0.546 . . . . 0.0 112.185 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.75 156.52 38.15 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.774 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.0 p -53.26 112.44 0.88 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.942 0.897 . . . . 0.0 112.231 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.48 29.32 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.941 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 p -115.26 143.27 45.5 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 122.649 -0.324 . . . . 0.0 110.324 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.6 p -116.68 153.73 31.82 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.43 0.157 . . . . 0.0 110.763 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.28 104.36 10.78 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -102.75 130.73 49.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.275 0.559 . . . . 0.0 110.721 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -79.67 104.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.211 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.06 -36.35 14.95 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -141.31 166.6 21.22 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -57.76 -42.58 58.11 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.984 1.789 . . . . 0.0 111.838 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -94.17 -25.3 17.16 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.029 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 45.4 t80 -102.66 114.07 28.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.022 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 43.1 m -122.09 133.24 54.78 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.3 tt0 -122.13 140.6 52.35 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 118.39 0.541 . . . . 0.0 111.107 -173.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 96.5 m -73.95 109.04 7.14 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.068 0.461 . . . . 0.0 110.652 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.423 -1.819 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.586 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -84.2 140.94 31.38 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -80.42 165.15 22.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -66.02 128.22 35.21 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 78.26 11.38 1.83 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.285 1.434 . . . . 0.0 112.039 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.83 162.03 25.05 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 33' ' ' SER . 46.0 tt0 -82.08 108.92 15.94 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.813 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -74.06 -62.23 1.58 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 17' ' ' THR . . . -176.84 88.79 0.08 OUTLIER Glycine 0 CA--C 1.474 -2.507 0 C-N-CA 119.08 -1.534 . . . . 0.0 112.585 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.1 -171.22 31.05 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.92 123.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 116.988 0.394 . . . . 0.0 110.226 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.27 21.88 46.99 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.784 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -109.85 146.14 35.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -135.11 25.37 3.56 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.76 -150.94 25.7 Favored Glycine 0 C--N 1.309 -0.943 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.6 115.59 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.421 2.081 . . . . 0.0 112.402 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.6 p -88.46 -21.34 24.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.204 0.525 . . . . 0.0 111.865 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.24 113.14 10.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 97.5 m -73.62 171.99 12.22 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.537 0.684 . . . . 0.0 112.093 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 159.57 32.96 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.279 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -67.65 112.27 4.68 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.04 13.15 32.26 Favored Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 81.4 p -128.37 155.87 44.01 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 p -121.22 143.04 49.35 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.206 -0.308 . . . . 0.0 111.29 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.06 100.7 8.31 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -102.18 134.09 45.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.501 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.81 98.5 6.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.378 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.79 -49.51 12.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.661 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 80.7 m-20 -128.98 166.27 26.24 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -56.62 -43.46 54.87 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.129 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -96.65 -25.21 15.65 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.26 0.552 . . . . 0.0 110.202 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 70.6 t80 -102.77 114.39 28.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.654 0.74 . . . . 0.0 111.795 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.1 m -125.25 144.65 50.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -133.25 141.66 48.14 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 118.056 0.389 . . . . 0.0 112.005 -172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.8 m -76.71 106.32 8.3 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.994 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.283 -2.29 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.132 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 55.7 p . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -113.54 140.29 48.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 m -91.05 173.32 8.01 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.728 -177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -56.27 131.55 48.33 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.163 0.985 . . . . 0.0 110.072 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 73.1 11.67 5.09 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.879 1.272 . . . . 0.0 112.3 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -98.27 160.13 20.62 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 177.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -80.86 101.83 9.66 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 p -73.16 -60.04 2.42 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.78 90.4 0.09 OUTLIER Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.112 -1.518 . . . . 0.0 113.136 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -100.17 -178.91 30.22 Favored Glycine 0 C--N 1.293 -1.815 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.33 116.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.69 11.9 49.1 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.378 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -109.36 111.15 22.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 p -104.12 31.51 4.52 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.182 0.515 . . . . 0.0 110.781 -177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.06 -153.53 24.24 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.501 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.44 102.86 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.642 2.228 . . . . 0.0 111.28 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.2 p -86.75 -15.71 38.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.27 124.92 40.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.4 m -79.66 176.32 9.82 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.261 0.553 . . . . 0.0 112.381 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' H62' ' A' ' 101' ' ' MAN . . . -87.09 177.41 7.21 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -60.48 122.51 14.81 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 123.116 0.566 . . . . 0.0 111.635 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.16 5.09 80.69 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.058 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.7 p -120.2 136.49 54.62 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 117.093 0.446 . . . . 0.0 110.58 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.0 p -109.82 144.92 37.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.801 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -81.56 96.09 7.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -95.61 130.97 42.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.001 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.1 101.63 8.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 mt -82.29 -44.18 16.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.735 0.779 . . . . 0.0 109.032 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -130.17 161.92 57.25 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.16 -34.81 98.55 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 121.675 1.584 . . . . 0.0 112.01 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 34.3 m-85 -100.65 -26.15 13.91 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.286 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 65.0 t80 -103.58 113.73 27.46 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.538 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.0 m -117.45 144.3 45.15 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.7 tt0 -130.4 138.39 50.34 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 118.34 0.518 . . . . 0.0 111.576 -173.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.0 m -75.06 108.61 7.91 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.353 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.47 HD21 ' OE1' ' A' ' 34' ' ' GLN . 88.9 mt . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 124.29 1.036 . . . . 0.0 108.352 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.491 ' H62' ' HA ' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -103.31 138.81 39.57 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.7 m -84.83 168.28 15.25 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.601 0.715 . . . . 0.0 111.662 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -60.86 125.67 24.56 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.024 0.929 . . . . 0.0 108.554 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 77.86 14.0 1.67 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.746 1.218 . . . . 0.0 112.735 -174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.56 153.57 20.46 Favored Glycine 0 C--O 1.25 1.125 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -73.01 99.58 2.77 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.2 p -66.27 -58.71 4.77 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.52 81.41 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.639 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.165 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.82 176.92 33.87 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.39 110.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 117.922 0.861 . . . . 0.0 109.561 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.93 -12.92 22.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.134 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -106.23 113.55 27.14 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -118.89 21.55 12.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.069 0.462 . . . . 0.0 111.477 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.7 -137.43 6.53 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.171 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.9 93.22 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.405 2.07 . . . . 0.0 112.22 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 31.9 p -86.4 -16.33 37.59 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.379 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.93 112.79 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.009 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.3 m -77.8 165.67 23.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.145 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.75 148.58 50.86 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.722 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -59.67 121.18 11.0 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.15 -15.33 28.09 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.679 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.2 p -117.44 147.79 42.39 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.559 -0.377 . . . . 0.0 109.999 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -117.23 153.75 32.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.3 t -78.78 101.14 7.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.47 134.07 40.11 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.36 0.6 . . . . 0.0 110.466 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.21 99.64 6.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.23 -49.09 11.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.72 0.771 . . . . 0.0 108.986 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -133.43 169.26 14.41 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.87 -44.14 22.23 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.445 1.43 . . . . 0.0 112.943 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -94.22 -25.08 17.22 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.449 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -103.11 114.29 28.46 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.231 0.539 . . . . 0.0 110.992 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 33.3 m -127.53 146.52 50.48 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -138.45 143.58 39.71 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.416 -170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.818 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.6 m -73.92 109.62 7.56 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.141 0.496 . . . . 0.0 111.127 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.234 0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 16' ' ' PRO . 7.8 tp-100 -81.49 144.06 31.61 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.9 m -85.24 168.27 14.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.227 0.537 . . . . 0.0 111.743 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -65.07 128.05 34.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 78.2 11.1 1.89 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.841 1.656 . . . . 0.0 111.829 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.55 158.11 26.09 Favored Glycine 0 C--O 1.247 0.951 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.5 tt0 -79.86 105.04 10.86 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.788 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.4 p -72.3 -57.71 3.99 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.65 76.48 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.533 -1.794 . . . . 0.0 113.396 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.68 178.18 31.01 Favored Glycine 0 C--N 1.291 -1.929 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.0 118.22 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.694 0.747 . . . . 0.0 108.991 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.11 -9.41 31.42 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.975 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.72 124.75 51.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 p -124.73 14.35 8.67 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 -147.3 11.16 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.195 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 19.3 Cg_endo -65.25 102.41 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.686 2.258 . . . . 0.0 112.297 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 13.8 p -87.27 -12.19 47.38 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.125 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.64 124.67 49.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.5 m -79.12 173.42 12.6 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.276 0.56 . . . . 0.0 111.75 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.63 162.86 28.17 Favored 'General case' 0 C--O 1.256 1.398 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.29 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.3 m -67.59 114.23 6.06 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.02 3.17 28.16 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.728 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.8 p -132.39 142.43 49.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 p -115.78 147.16 41.26 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.604 0.24 . . . . 0.0 110.975 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.92 97.69 6.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.37 124.2 37.19 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.001 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.64 107.87 15.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CE2' ' A' ' 32' ' ' TYR . 81.9 mt -90.07 -42.59 11.03 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.732 0.777 . . . . 0.0 109.019 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -132.63 165.38 36.81 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.17 -35.48 98.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.431 1.421 . . . . 0.0 111.985 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -98.62 -26.45 14.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.815 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CE2' HD12 ' A' ' 28' ' ' LEU . 57.4 t80 -103.88 114.27 28.4 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.312 0.577 . . . . 0.0 112.096 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -124.2 136.6 54.29 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -129.33 139.07 51.87 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.861 0.363 . . . . 0.0 111.801 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.788 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -73.63 105.93 5.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.285 -2.224 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.5 p . . . . . 0 CA--C 1.507 -0.697 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 9.0 tp-100 -108.78 140.38 42.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -79.82 163.9 24.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.076 0.465 . . . . 0.0 111.559 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -63.4 127.85 33.17 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 78.34 11.94 1.71 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.628 1.171 . . . . 0.0 112.343 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 159.15 19.31 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -80.83 102.41 10.0 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.742 0.306 . . . . 0.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.803 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.6 p -65.31 -42.4 93.05 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.659 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 112.42 0.77 Allowed Glycine 0 N--CA 1.406 -3.333 0 C-N-CA 118.866 -1.635 . . . . 0.0 113.627 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.65 -161.46 28.96 Favored Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.54 117.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.22 -8.26 32.99 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.744 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -106.56 130.08 54.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 p -130.78 3.88 4.52 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.23 -131.78 1.0 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.578 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.7 87.98 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.806 2.337 . . . . 0.0 112.496 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.0 p -93.36 -15.06 26.12 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.73 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -79.99 116.75 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.467 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -76.53 174.39 10.38 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.954 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 158.64 35.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.745 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -65.84 112.35 3.71 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.411 0.624 . . . . 0.0 109.806 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.8 -6.68 31.27 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.376 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.4 p -115.51 148.6 39.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 p -116.65 146.06 42.99 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.994 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -78.33 100.04 6.58 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -97.76 130.66 44.7 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.201 0.524 . . . . 0.0 109.741 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.2 t -85.83 94.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.33 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.6 mt -70.05 -54.85 11.29 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -123.66 160.64 50.23 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.74 -42.85 64.74 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 122.521 2.147 . . . . 0.0 112.599 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -93.24 -25.37 17.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.163 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -103.09 113.97 27.88 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.359 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 m -125.32 138.93 54.07 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -130.61 143.05 50.49 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.136 0.273 . . . . 0.0 111.308 -172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.803 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.0 m -77.37 108.11 10.27 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.483 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.414 -2.245 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -85.95 137.3 32.83 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 m -80.27 163.97 23.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.435 0.636 . . . . 0.0 112.574 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -62.84 129.74 41.78 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 78.0 11.65 1.91 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.997 1.319 . . . . 0.0 112.068 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.49 152.81 20.28 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -75.21 117.82 17.46 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -84.37 -57.6 3.09 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.1 91.81 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 118.519 -1.801 . . . . 0.0 113.703 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -99.61 -171.13 30.4 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.7 mt -60.18 117.26 2.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 117.498 0.649 . . . . 0.0 109.747 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 -12.25 47.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.07 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -88.35 114.56 25.09 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -115.08 18.41 16.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.023 0.44 . . . . 0.0 111.8 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.17 -143.87 15.76 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.856 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.56 106.33 1.94 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.277 2.651 . . . . 0.0 112.926 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.3 p -100.23 -9.03 22.85 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.215 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.83 108.78 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.7 m -71.38 166.0 22.59 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 123.065 0.546 . . . . 0.0 112.162 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.78 174.13 9.6 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.441 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.56 127.64 33.73 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.017 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.27 63.63 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.288 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.3 p -104.9 155.15 19.19 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.0 p -129.38 148.35 51.29 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 122.157 0.183 . . . . 0.0 110.519 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.64 97.03 4.97 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -94.62 129.86 41.31 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.116 0.484 . . . . 0.0 110.493 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.81 94.08 3.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.423 HD12 ' CE1' ' A' ' 32' ' ' TYR . 91.1 mt -75.18 -41.92 56.92 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -136.92 163.72 47.46 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -56.49 -38.71 94.83 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.044 1.829 . . . . 0.0 112.024 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.5 m-85 -95.0 -26.07 16.23 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.949 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' CE1' HD12 ' A' ' 28' ' ' LEU . 49.7 t80 -103.44 114.43 28.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.329 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -125.1 138.56 54.17 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.92 142.62 50.38 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 117.796 0.271 . . . . 0.0 111.032 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -75.43 103.53 5.6 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.243 0.544 . . . . 0.0 110.039 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.288 -2.108 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.216 -0.703 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.4 tp-100 -88.41 145.0 26.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -85.18 167.83 15.35 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.1 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -65.1 129.09 38.45 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 77.08 12.07 2.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.012 1.325 . . . . 0.0 111.738 -176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.73 156.52 21.05 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.89 108.81 12.62 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.836 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -70.69 -63.08 1.16 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.494 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 173.55 95.13 0.1 OUTLIER Glycine 0 N--CA 1.411 -3.021 0 C-N-CA 118.182 -1.961 . . . . 0.0 113.348 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.9 -164.47 30.12 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.34 123.01 12.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 117.481 0.641 . . . . 0.0 110.103 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.56 70.34 Favored Glycine 0 C--N 1.315 -0.635 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.864 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 36.4 t80 -100.25 129.56 46.27 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -131.0 14.76 5.23 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.8 -133.4 3.16 Favored Glycine 0 C--O 1.244 0.741 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 42.2 Cg_endo -69.23 89.42 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.443 2.095 . . . . 0.0 112.2 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 20.9 p -85.74 -21.01 28.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -91.42 122.6 42.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 74.5 m -74.32 157.71 35.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.827 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 153.63 38.47 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 m -49.83 119.67 3.7 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.899 0.88 . . . . 0.0 111.685 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.72 -14.31 38.36 Favored Glycine 0 N--CA 1.431 -1.665 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.538 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 72.9 p -113.53 146.37 39.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 117.265 0.532 . . . . 0.0 110.958 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.9 p -111.67 150.8 29.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.93 101.22 9.34 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -95.28 127.38 41.28 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.348 0.594 . . . . 0.0 110.72 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.72 100.0 6.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.326 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.44 -44.08 14.02 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -134.57 163.45 51.13 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -58.28 -41.69 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.997 1.798 . . . . 0.0 112.882 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -95.93 -25.84 15.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.518 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -102.78 113.99 27.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.814 0.816 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 34.6 m -124.68 138.63 54.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 175.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.49 140.49 52.9 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 118.067 0.394 . . . . 0.0 110.884 -172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.836 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.6 m -74.33 106.83 6.14 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.415 -2.211 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.392 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 16' ' ' PRO . 6.5 tp-100 -88.61 142.14 27.94 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.041 0.448 . . . . 0.0 110.783 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -82.67 164.98 20.37 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.978 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -64.72 131.86 48.04 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 78.35 11.65 1.75 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.036 1.334 . . . . 0.0 112.001 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.97 162.44 15.41 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.8 tt0 -81.41 108.22 14.83 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -70.52 -65.57 0.71 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.459 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.18 83.82 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.463 0 C-N-CA 119.207 -1.473 . . . . 0.0 112.564 -176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.66 -168.32 36.74 Favored Glycine 0 N--CA 1.429 -1.81 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -61.57 123.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 117.645 0.722 . . . . 0.0 109.314 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.87 -20.28 51.37 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.152 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -101.58 115.37 30.37 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.3 p -125.27 23.87 7.52 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.047 0.451 . . . . 0.0 110.797 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.55 -134.66 0.57 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 55.9 Cg_endo -72.12 88.31 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.475 1.638 . . . . 0.0 110.76 175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.6 p -80.41 -24.22 39.81 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -173.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -86.89 136.02 23.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.9 m -90.0 -173.54 3.91 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.426 0.632 . . . . 0.0 112.633 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.6 160.93 28.99 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.036 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -62.82 116.69 5.47 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 -6.43 46.43 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.074 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -114.31 142.12 46.72 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.55 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.1 p -114.43 152.65 31.25 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.572 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.84 100.95 9.88 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.53 137.69 37.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.955 0.407 . . . . 0.0 110.597 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.6 116.21 26.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -102.68 -41.07 6.34 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.382 0.61 . . . . 0.0 109.494 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 79.4 m-20 -136.85 167.46 21.08 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.63 -43.29 59.04 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.458 2.106 . . . . 0.0 113.799 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -101.96 -24.66 13.97 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.606 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 66.1 t80 -96.56 114.54 26.2 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 122.148 0.975 . . . . 0.0 110.825 -177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 30.7 m -125.14 141.77 51.9 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -128.62 143.19 50.9 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 117.888 0.313 . . . . 0.0 111.266 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 72.4 m -76.46 108.2 9.27 Favored 'General case' 0 C--O 1.248 0.988 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.542 176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.44 -0.939 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.9 tp-100 -99.63 133.41 44.0 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -73.06 166.86 22.29 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.191 0.52 . . . . 0.0 111.356 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -67.95 131.09 44.84 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 77.33 12.0 2.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.75 1.22 . . . . 0.0 111.723 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.84 163.16 22.32 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.606 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.62 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.5 tt0 -83.38 101.96 11.7 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.133 0.573 . . . . 0.0 110.042 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.776 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.5 p -67.15 -56.29 10.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.97 88.66 0.07 OUTLIER Glycine 0 N--CA 1.425 -2.075 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.783 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -98.69 -169.64 31.29 Favored Glycine 0 C--N 1.3 -1.471 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.11 118.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 118.195 0.997 . . . . 0.0 110.276 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.43 -16.3 48.83 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.95 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -109.63 121.41 45.14 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -137.8 15.81 2.89 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.96 -127.09 0.4 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.596 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.83 93.97 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.828 2.352 . . . . 0.0 111.758 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.87 -12.28 19.99 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.048 -172.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.7 t -88.32 113.03 24.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 72.7 m -71.87 145.08 48.8 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.442 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 155.23 10.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.275 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 m -48.44 115.59 1.28 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.59 1.156 . . . . 0.0 112.153 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.8 -19.96 32.34 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.686 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.533 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 55.4 p -104.22 145.59 29.99 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.822 -176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.8 p -116.64 136.28 53.1 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.499 0.5 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 52.5 t -74.93 110.77 9.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -117.9 138.49 52.09 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.438 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.34 108.54 16.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.518 HD12 ' CE2' ' A' ' 32' ' ' TYR . 87.4 mt -89.35 -44.93 9.86 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.277 0.56 . . . . 0.0 109.556 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -131.18 163.43 49.33 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.16 -38.31 95.12 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.954 1.77 . . . . 0.0 112.391 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 67.0 m-85 -95.63 -25.06 16.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.501 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.518 ' CE2' HD12 ' A' ' 28' ' ' LEU . 48.6 t80 -103.71 113.51 27.08 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.27 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 22.2 m -121.6 136.14 54.96 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -128.42 141.92 51.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 78.3 m -79.14 103.56 9.16 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.038 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--N 1.292 -1.903 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.31 177.886 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.239 0.536 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.65 143.48 31.88 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -85.64 162.11 18.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.612 0.72 . . . . 0.0 111.522 -174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -59.43 131.22 50.32 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.4 1.08 . . . . 0.0 108.559 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 74.92 12.07 3.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.09 0.956 . . . . 0.0 112.959 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.48 155.64 18.43 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.1 tt0 -75.19 112.3 11.32 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.4 p -77.61 -53.08 8.01 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.552 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.11 99.84 0.13 Allowed Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.597 -1.763 . . . . 0.0 113.37 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.55 -161.21 29.03 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.25 111.17 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 117.35 0.575 . . . . 0.0 110.332 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.49 21.98 12.08 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.298 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -109.73 124.32 51.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.098 -0.648 . . . . 0.0 109.448 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.1 p -113.74 8.39 17.46 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.424 0.63 . . . . 0.0 112.19 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.65 -151.65 23.77 Favored Glycine 0 C--N 1.309 -0.956 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.666 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.26 109.76 2.91 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.544 2.163 . . . . 0.0 112.431 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.5 p -92.25 -18.18 23.78 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.844 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.24 121.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.6 m -81.87 175.92 10.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.917 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.83 162.39 29.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.131 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -62.43 112.35 2.41 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 123.725 0.64 . . . . 0.0 110.188 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.95 38.91 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.077 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.6 p -122.84 139.54 53.91 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -111.67 148.74 32.74 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.7 t -76.98 100.06 5.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -100.81 138.06 38.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.256 0.55 . . . . 0.0 110.425 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -84.34 105.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.932 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.38 -44.68 11.18 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -132.35 164.03 46.24 Favored Pre-proline 0 C--N 1.308 -1.238 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.95 -40.77 81.7 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.035 1.824 . . . . 0.0 112.252 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -96.3 -25.39 15.79 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.216 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 54.7 t80 -102.34 114.16 28.1 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.515 0.674 . . . . 0.0 111.489 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 47.4 m -120.04 139.14 52.97 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 35.8 tt0 -129.91 143.11 50.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 118.063 0.392 . . . . 0.0 111.66 -172.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.5 m -75.5 106.51 7.08 Favored 'General case' 0 C--O 1.255 1.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--O 1.265 1.895 0 C-N-CA 124.566 1.147 . . . . 0.0 108.683 -179.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.426 HG21 ' O5 ' ' A' ' 101' ' ' MAN . 23.6 p . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.591 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.8 tp-100 -94.92 139.56 31.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 m -81.38 172.19 13.85 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 120.89 0.376 . . . . 0.0 110.901 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.79 133.36 53.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 76.11 11.23 2.97 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.476 1.11 . . . . 0.0 112.583 -175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.43 154.09 20.62 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 119.636 -1.269 . . . . 0.0 111.283 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 33' ' ' SER . 65.9 tt0 -74.76 96.84 3.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.806 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.6 p -63.39 -56.4 16.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.92 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.07 95.7 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.209 0 C-N-CA 119.365 -1.398 . . . . 0.0 112.022 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.13 -169.59 30.7 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.0 113.01 3.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 117.81 0.805 . . . . 0.0 108.911 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.2 -0.97 37.83 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.169 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -109.35 116.66 32.26 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 p -115.89 15.32 16.29 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.84 -146.0 2.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.205 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 31.6 Cg_endo -70.33 101.03 0.94 Allowed 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.044 1.829 . . . . 0.0 111.575 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 12.9 p -86.27 -23.96 26.15 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.642 -172.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -89.33 137.82 20.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.14 -174.85 5.08 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 120.787 0.327 . . . . 0.0 111.617 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.22 169.78 16.17 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.645 0.26 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -64.11 112.42 2.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.46 -4.71 33.05 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.201 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 45.5 p -121.77 145.52 47.97 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 116.867 0.334 . . . . 0.0 110.773 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -118.93 157.79 27.0 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.71 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -84.92 103.79 14.29 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -100.74 132.37 46.16 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.483 0.659 . . . . 0.0 110.48 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.15 101.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.689 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.31 -51.65 6.82 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -127.57 169.43 12.39 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.62 -43.64 12.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.446 1.431 . . . . 0.0 111.514 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.92 -26.02 16.31 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.284 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -103.13 114.2 28.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.992 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 38.8 m -125.91 141.95 51.74 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -132.01 144.64 50.93 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -169.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 95.4 m -75.79 111.02 10.7 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.612 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.423 -1.822 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.178 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.426 ' O5 ' HG21 ' A' ' 1' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.516 -0.362 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.5 tp-100 -82.58 137.46 34.54 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -82.73 169.17 16.48 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 120.78 0.324 . . . . 0.0 111.579 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -56.98 130.22 45.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.929 0.892 . . . . 0.0 109.815 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 75.02 11.92 3.53 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.807 1.243 . . . . 0.0 113.524 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.92 161.24 22.63 Favored Glycine 0 N--CA 1.438 -1.211 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' SER . 50.4 tt0 -81.42 105.15 12.37 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.782 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -68.83 -62.42 1.39 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -175.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.14 82.59 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 118.835 -1.65 . . . . 0.0 113.054 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.19 177.43 29.93 Favored Glycine 0 C--N 1.295 -1.741 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.1 mt -62.17 117.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 118.103 0.951 . . . . 0.0 110.221 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.82 -15.51 26.34 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.159 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -100.2 135.27 41.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 p -133.14 14.32 4.22 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.31 -147.89 9.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.171 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 28.5 Cg_endo -66.59 102.77 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.2 1.933 . . . . 0.0 111.272 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.1 p -86.88 -15.14 39.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.615 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.63 130.81 39.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.7 m -80.51 163.06 24.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.104 0.478 . . . . 0.0 112.038 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.02 154.05 20.01 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.063 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 m -60.02 113.29 2.24 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.172 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.48 -15.43 27.22 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.879 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.4 p -110.68 148.86 31.39 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -118.39 148.05 42.92 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 121.355 -0.138 . . . . 0.0 111.174 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -78.38 101.38 7.21 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -97.05 130.22 44.38 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.083 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -85.42 98.48 6.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.064 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.5 mt -81.26 -42.3 20.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -135.96 164.93 39.65 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.99 -30.72 94.13 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.161 1.907 . . . . 0.0 112.019 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -104.94 -27.03 11.93 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.772 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -103.49 115.09 29.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.678 0.752 . . . . 0.0 111.121 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 35.4 m -124.39 138.23 54.38 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -126.21 141.08 52.07 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.056 0.389 . . . . 0.0 111.357 -172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 98.3 m -76.73 103.74 6.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.337 0.589 . . . . 0.0 111.473 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.064 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -92.61 138.4 31.53 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -82.04 169.71 16.39 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.216 0.531 . . . . 0.0 111.604 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -64.78 136.67 57.16 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 70.4 11.84 7.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.894 0.877 . . . . 0.0 111.825 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.45 156.45 21.61 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -78.54 103.0 8.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.8 p -66.08 -47.29 74.77 Favored 'General case' 0 C--O 1.206 -1.22 0 O-C-N 123.634 0.584 . . . . 0.0 110.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.26 106.85 0.28 Allowed Glycine 0 N--CA 1.413 -2.85 0 C-N-CA 118.788 -1.673 . . . . 0.0 113.828 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.07 -161.16 29.51 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -59.7 121.84 8.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 117.357 0.579 . . . . 0.0 111.427 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.45 -18.45 56.98 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.269 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -82.77 111.19 18.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.277 0.56 . . . . 0.0 109.5 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 p -108.16 12.9 26.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.537 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.15 -155.06 20.96 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.656 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.86 99.91 0.68 Allowed 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.355 2.037 . . . . 0.0 112.787 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.6 p -90.44 -7.87 51.99 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.763 -175.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.31 111.49 22.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 84.3 m -75.29 169.36 18.2 Favored 'General case' 0 C--O 1.256 1.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.34 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 142.15 51.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.185 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -61.28 119.73 9.02 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.77 -20.49 22.26 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.7 p -105.76 148.3 27.63 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -119.16 139.7 51.39 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.15 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.6 t -70.61 112.06 6.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 47.6 mt-30 -112.6 135.73 52.98 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.18 0.514 . . . . 0.0 110.856 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.5 t -83.85 98.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.039 -176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.16 -56.58 4.13 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -122.32 168.08 12.54 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.55 -42.9 49.98 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.125 1.883 . . . . 0.0 112.685 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -100.02 -25.3 14.36 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -101.78 114.19 28.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.892 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 50.6 m -123.31 139.07 54.42 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.75 142.11 51.64 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 117.933 0.333 . . . . 0.0 111.278 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.3 m -78.67 108.93 12.45 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.081 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 26' ' ' GLN . 96.5 mt . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 63.5 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 128.85 38.29 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 m -82.56 172.94 12.43 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.166 0.508 . . . . 0.0 112.01 -174.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -59.86 128.17 35.57 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.813 0.845 . . . . 0.0 109.149 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 77.67 12.11 2.0 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.128 0.971 . . . . 0.0 112.839 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.45 159.21 21.09 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.0 tt0 -84.73 114.25 21.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.7 p -79.91 -59.58 2.67 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.57 79.17 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.218 0 C-N-CA 118.563 -1.779 . . . . 0.0 113.453 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.93 -178.49 31.95 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.82 119.61 3.65 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.163 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.9 -7.6 60.86 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.981 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -106.51 131.04 54.14 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.115 0.458 . . . . 0.0 109.798 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 p -138.62 19.55 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.65 -139.15 2.29 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.211 -0.772 . . . . 0.0 111.787 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.78 102.86 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 122.204 1.936 . . . . 0.0 111.606 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.9 p -94.03 -24.99 17.4 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.004 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.55 123.97 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.534 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -77.87 160.6 28.19 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 112.054 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 161.38 30.57 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.04 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.1 m -54.39 116.97 2.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.085 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.21 42.37 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.28 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.473 ' HA ' ' OXT' ' A' ' 36' ' ' LEU . 76.9 p -115.61 147.98 40.15 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.394 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -121.41 146.57 46.75 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.922 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -77.14 117.1 18.36 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -113.85 132.83 55.75 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.7 t -86.44 94.96 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.85 -41.0 60.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.823 0.82 . . . . 0.0 109.535 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 32' ' ' TYR . 41.5 m-80 -139.24 163.39 46.12 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -54.55 -42.8 64.88 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.159 1.906 . . . . 0.0 112.653 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -94.32 -25.97 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.848 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 34' ' ' GLN . 44.2 t80 -103.51 114.21 28.31 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.815 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.3 m -121.04 135.1 55.28 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 35.6 tt0 -126.19 142.54 51.49 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 117.809 0.277 . . . . 0.0 110.819 -171.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 83.9 m -77.08 110.08 11.45 Favored 'General case' 0 C--O 1.253 1.286 0 CA-C-O 121.284 0.564 . . . . 0.0 110.745 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.473 ' OXT' ' HA ' ' A' ' 23' ' ' THR . 89.9 mt . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.281 1.432 . . . . 0.0 107.478 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 tp-100 -81.51 140.78 34.35 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.813 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -88.36 173.01 8.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.078 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -64.65 126.92 29.43 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.472 0.709 . . . . 0.0 109.484 -176.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 75.39 14.55 2.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.973 1.309 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.9 151.47 19.21 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.63 107.02 9.8 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 117.144 0.472 . . . . 0.0 110.226 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.3 p -72.51 -27.91 62.55 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.88 129.46 6.07 Favored Glycine 0 N--CA 1.4 -3.725 0 C-N-CA 119.424 -1.37 . . . . 0.0 115.234 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.32 -159.31 29.09 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 107.034 -2.426 . . . . 0.0 107.034 171.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 64.8 mt -53.12 126.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 117.27 0.535 . . . . 0.0 110.581 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -30.4 8.73 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.753 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -81.39 129.84 34.8 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.2 p -125.15 10.11 8.08 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.37 -137.49 2.66 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.577 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.17 90.2 0.77 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.019 1.812 . . . . 0.0 111.833 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.3 p -81.14 -16.5 52.81 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.193 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.12 132.18 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.8 m -83.3 175.96 9.5 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.94 144.23 38.98 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.7 m -52.69 122.08 8.39 Favored 'General case' 0 C--O 1.247 0.932 0 O-C-N 123.454 0.471 . . . . 0.0 110.319 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.64 -12.31 27.75 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.943 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.5 p -122.8 144.64 49.05 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.4 p -111.49 141.62 44.82 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.345 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.5 t -76.45 97.83 4.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -92.91 126.28 37.92 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.084 0.468 . . . . 0.0 109.767 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -81.44 94.03 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.218 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.05 -49.03 21.06 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.792 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.84 163.86 44.23 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -55.05 -39.21 92.08 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 122.493 2.128 . . . . 0.0 113.114 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 87.7 m-85 -100.61 -24.63 14.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.521 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -103.13 114.39 28.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.436 0.636 . . . . 0.0 111.297 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -129.91 140.91 50.87 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.411 HE21 HD21 ' A' ' 36' ' ' LEU . 29.9 tt0 -134.8 144.08 47.44 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.55 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 70.1 m -76.48 107.33 8.68 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.251 0.548 . . . . 0.0 110.961 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.411 HD21 HE21 ' A' ' 34' ' ' GLN . 95.7 mt . . . . . 0 N--CA 1.412 -2.328 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.538 ' H61' ' O3 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.444 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.2 tp-100 -87.05 125.51 34.15 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -79.81 171.5 15.03 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.062 0.458 . . . . 0.0 111.898 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -60.4 133.22 55.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 74.97 12.05 3.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.171 0.988 . . . . 0.0 112.155 -176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.74 159.58 20.94 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.0 tt0 -83.7 110.96 18.73 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 4.1 p -72.24 -62.02 1.58 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.508 ' HA3' HG22 ' A' ' 17' ' ' THR . . . 178.61 92.86 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.335 0 C-N-CA 119.21 -1.472 . . . . 0.0 112.72 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.51 29.39 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.43 115.52 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 117.083 0.442 . . . . 0.0 110.762 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -1.91 47.65 Favored Glycine 0 C--N 1.311 -0.85 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.382 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -95.18 112.08 23.83 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -108.27 9.17 28.03 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.82 -157.02 31.13 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.264 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.15 110.56 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.704 2.269 . . . . 0.0 112.161 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 40.4 p -92.63 -0.6 57.28 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.511 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -83.62 114.94 25.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.88 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 71.4 m -77.87 167.36 21.63 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.272 0.558 . . . . 0.0 111.708 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.24 175.78 7.26 Favored 'General case' 0 C--O 1.251 1.151 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.871 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.5 m -68.73 129.19 39.2 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.407 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.54 74.77 Favored Glycine 0 C--N 1.31 -0.907 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.352 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -123.94 141.1 52.34 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 120.637 0.256 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -118.81 154.61 32.58 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.982 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.1 t -79.81 104.53 10.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -104.82 127.7 52.73 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.15 103.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.019 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.81 -44.64 15.27 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -133.98 166.91 25.71 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.11 -43.56 41.28 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.975 1.783 . . . . 0.0 112.826 -177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -95.06 -25.43 16.47 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.978 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -102.72 114.17 28.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.818 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -123.2 138.61 54.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -124.99 142.68 51.33 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 118.25 0.477 . . . . 0.0 111.345 -171.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.9 m -76.73 106.82 8.62 Favored 'General case' 0 C--O 1.254 1.316 0 CA-C-O 121.288 0.566 . . . . 0.0 110.094 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.912 -179.702 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -80.68 140.63 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 118.067 0.394 . . . . 0.0 110.129 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -69.03 160.21 31.4 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.818 0.847 . . . . 0.0 112.406 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -66.94 128.42 36.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 70.11 23.95 5.13 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.941 0.896 . . . . 0.0 111.351 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 151.69 17.21 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 171.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -78.54 104.52 9.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 117.408 0.604 . . . . 0.0 110.864 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.8 p -68.13 -31.77 71.58 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.84 130.37 6.29 Favored Glycine 0 N--CA 1.401 -3.641 0 C-N-CA 119.107 -1.521 . . . . 0.0 115.396 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.11 -159.52 29.32 Favored Glycine 0 N--CA 1.41 -3.035 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.462 ' O ' ' HD1' ' A' ' 31' ' ' TYR . 73.9 mt -53.22 123.59 4.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.262 0.553 . . . . 0.0 110.989 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.25 -26.92 17.2 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.973 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -88.7 111.08 21.54 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.7 p -107.28 25.89 10.86 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.24 -143.97 11.23 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.17 99.0 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.875 1.716 . . . . 0.0 111.286 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -89.49 -22.23 22.57 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.371 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.6 t -81.21 117.62 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 90.7 m -75.04 159.83 31.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.36 150.16 11.94 Favored 'General case' 0 C--O 1.25 1.128 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.231 176.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.677 ' OG ' ' H4 ' ' A' ' 101' ' ' MAN . 16.0 m -65.45 112.15 3.42 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.73 1.86 30.57 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.967 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 p -123.01 152.0 41.33 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 p -113.37 146.65 39.12 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.668 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.14 99.1 8.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -97.07 120.68 37.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.748 -175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -72.19 102.73 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.892 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 32' ' ' TYR . 94.6 mt -87.14 -42.72 12.8 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 75.7 m-20 -135.16 165.43 36.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.49 -38.51 64.31 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.691 2.261 . . . . 0.0 113.951 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 11' ' ' ILE . 68.0 m-85 -106.57 -18.64 13.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.162 0.506 . . . . 0.0 110.793 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 44.3 t80 -101.56 114.49 28.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.925 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 m -132.42 134.46 45.15 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.409 HE21 HD21 ' A' ' 36' ' ' LEU . 25.1 tt0 -130.34 144.44 51.38 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.377 0.423 . . . . 0.0 111.394 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.72 104.81 5.51 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.48 0.657 . . . . 0.0 111.107 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD21 HE21 ' A' ' 34' ' ' GLN . 88.4 mt . . . . . 0 N--CA 1.409 -2.509 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.677 ' H4 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_